Virios Therapeutics ( NASDAQ: VIRI ) has announced the pricing of its previously announced public offering of 8.5 million shares of its common stock at a public offering price of $0.20 per share, for an expected gross proceeds to be approximately $1.
7 million. The offering is expected to close on May 22, 2024. The company intends to use the net proceeds of the proposed offering to commence preparatory activities for its planned IMC-2 Long-COVID Phase 2b study and for general corporate purposes.
Shares in the company were down 34.01% in premarket trading on Monday. More on Virios Therapeutics Virios Therapeutics announces proposed public offering of common stock Seeking Alpha’s Quant Rating on Virios Therapeutics Historical earnings data for Virios Therapeutics Financial information for Virios Therapeutics.
